Kellogg Healthcare Deep Dive
Boston Alumni Networking Event
Featuring
Jeff Walsh ’93 MBA
CEO of nChroma Bio
Friday, February 14, 2025
6:00 PM - 8:00 PM Eastern Time
Omni Hotel Boston at the Seaport
450 Summer St
Boston, Massachusetts
Please join us for our Healthcare at Kellogg Boston Deep Dive Alumni Networking event, featuring Jeff Walsh ’93 MBA, CEO of nChroma Bio. Walsh will discuss his career building and leading early-stage biopharma companies.
This alumni event coordinates with the Healthcare at Kellogg Deep Dive, an immersive program bringing together Full-time, Evening & Weekend and Executive MBA students to take classes and network together over three weekends in Evanston and Boston.
Jeff Walsh brings over 30 years of experience in leadership positions with public and private life sciences companies. Walsh was CEO of Nvelop Therapeutics prior to its strategic merger with Chroma Medicine in December 2024. He was a venture partner at Third Rock Ventures (TRV), evaluating next generation gene and cell therapy opportunities. Prior to TRV, he held executive roles at bluebird bio from 2011-2020, including chief financial and strategy officer and chief operating officer. Walsh previously served as chief business and financial officer of Taligen Therapeutics, Inc. through its sale to Alexion Pharmaceuticals. He also held business development and finance roles at Pathogenesis (sold to Chiron), EXACT Sciences, Allscripts and SmithKline Beecham. Walsh currently serves on the Board of Directors at Tenaya Therapeutics and Tevard Biosciences and is an Executive Teaching Fellow at Boston University’s Questrom School of Business. He received his B.A. from Yale University and M.B.A. from the Kellogg Graduate School of Management at Northwestern University.